DNADX
LIVE

Serial Number

79365402

Owner

REVEAL GENOMICS S.L.

Attorney

Donna A. Tobin

Filing Date

Feb 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DNADX Trademark

Serial Number: 79365402 • Registration: 7504655

DNADX is a trademark filed by REVEAL GENOMICS S.L. on February 6, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

REVEAL GENOMICS S.L. (4 trademarks)

Villarroel 170, 2, Planta 5

Entity Type: 16

Trademark Details

Filing Date

February 6, 2023

Registration Date

September 17, 2024

Published for Opposition

July 2, 2024

Goods & Services

Diagnostic preparations for medical purposes, in the field of cancer; diagnostic reagents for medical use, in the field of cancer; diagnostic biomarker reagents for medical purposes, in the field of cancer; clinical medical reagents, in the field of cancer; medical diagnostic reagents for use in analysis of circulating tumor DNA extracted from blood samples, for use in the field of cancer; medical diagnostic reagents for use in diagnostic tests, in the field of cancer; biomarkers being copy number alterations and gene mutation for the diagnosis, prognosis and treatment of cancer; medical diagnostic reagents and assays for the diagnosis, prognosis and treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; compounds, namely, chemotherapy drugs, inmunotherapy agents, targeted drug therapies and hormonal therapies for treating cancer; pharmaceutical preparations for use in oncology; biological reagents for medical use, in the field of cancer; diagnostic reagent kits comprised of medical diagnostic reagents and assays for testing body fluids for medical use in the field of cancer.

Diagnostic preparations for scientific purposes, in the field of cancer; reagents for research purposes, in the field of cancer; reagents for medical research, in the field of cancer; diagnostic reagents for scientific or research use, in the field of cancer; reagents for scientific or research use in the field of cancer; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, in the field of cancer

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 15, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 24, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 24, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 17, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 31, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 14, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2024 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 11, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 12, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 12, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 12, 2024 COAR
REFUSAL PROCESSED BY IB
Nov 28, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 7, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 7, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 4, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 3, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 16, 2023 REPR